However, Revenue from operations fell by 15.16% YoY to Rs 774.20 crore during the quarter. On the segmental front, revenue from the Poultry and Poultry Products business amounted to Rs 451.69 crore, registering a 5.83% year-on-year (YoY) growth. Revenue from Animal Health products stood at Rs 80.32 crore, marking a 6.58% YoY increase. In contrast, the Oilseed business reported revenues of Rs 269.63 crore, registering a decline of 38.17% YoY. Total expenses declined by 11.75% to Rs 773.23 crore in the second quarter as compared with the same period last year, primarily due to lower raw material costs (down 19.97% YoY). This was, to some extent, offset by higher employee expenses (up 8.19% YoY) and higher other expenses (up 7.12% YoY). Profit before tax stood at Rs 11 crore in the quarter ended 30 September 2024, down 75.98% as compared to Rs 45.81 crore reported in Q2 FY24. On half-year basis, the company's net profit surged 55.02% to Rs 82.94 crore despite of 16.24% decrease in revenue to Rs 1,582.22 crore in H1 FY25 over H1 FY24. Venky's said, 'Poultry and Poultry Products segment were affected due to lower realisations as a result of seasonal pattern and fluctuations in demand for chicken products. Oilseed segments sales turnover and margins were affected due to unfavorable market conditions. Performance of Animal Health Products segment has been satisfactory.' Venkys (India) is the largest fully integrated poultry group in Asia. Its diversified products include SPF eggs, chicken and eggs processing, broiler and layer breeding, genetic research and Poultry diseases diagnostic, Poultry vaccines and feed supplements, vaccine pro. Powered by Capital Market - Live

Net profit of Venky's (India) declined 77.24% to Rs 7.76 crore in the quarter ended September 2024 as against Rs 34.09 crore during the previous quarter ended September 2023. Sales declined 15.17% to Rs 774.20 crore in the quarter ended September 2024 as against Rs 912.60 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales774.20912.60 -15 OPM %1.795.44 - PBDT19.8654.50 -64 PBT11.0045.81 -76 NP7.7634.09 -77 Powered by Capital Market - Live

Venkys (India) will hold a meeting of the Board of Directors of the Company on 7 November 2024.Powered by Capital Market - Live

Venkys (India) has fixed 23 August 2024 as record date for the purpose of deciding eligibility of shareholders entitled to receive dividend on equity shares, if approved. Powered by Capital Market - Live

The company's net profit surged 287.33% to Rs 75.18 crore on 17.25% decline in revenue from operations to Rs 808.02 crore in Q1 June 2024 over Q1 June 2023. Profit before tax soared 278.64% year-on-year to Rs 100.87 crore in Q1 June 2024. Total expenses declined by 25.17% to Rs 717.63 crore in the first quarter as against the same period last year, primarily due to lower raw material costs (down 33.34% YoY). Meanwhile, employee expenses was up 6.23% YoY and other expenses was up 2.67% YoY. On the segmental front, revenue from Poultry and Poultry Products business rose 17.74% at Rs 513.80 crore. The Animal Health Products business posted revenue of Rs 83.51 crore, up 5.35% YoY. Meanwhile, Oilseed business reported revenues of Rs 237.94 crore, down 51.28% YoY. Venky's reported improved profit margins in its poultry and poultry products segment, driven by improved realizations from sale of day old chicks and grown up birds. However, the oilseed segment faced margin pressures due to lower sales, reduced raw material costs, and subdued finished product prices. The company's animal health products division delivered satisfactory performance. Venkys (India) is Asia's largest fully integrated poultry group. Its diverse operations encompass SPF eggs, chicken and egg processing, broiler and layer breeding, genetic research, poultry disease diagnostics, and vaccine production. Powered by Capital Market - Live

Net profit of Venky's (India) rose 287.33% to Rs 75.18 crore in the quarter ended June 2024 as against Rs 19.41 crore during the previous quarter ended June 2023. Sales declined 17.25% to Rs 808.02 crore in the quarter ended June 2024 as against Rs 976.44 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales808.02976.44 -17 OPM %12.783.17 - PBDT109.7335.44 210 PBT100.8726.64 279 NP75.1819.41 287 Powered by Capital Market - Live

Venkys (India) will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live